Safety and Efficacy of PD-1/PD-L1 Inhibitors in Cancer Patients With Preexisting Autoantibodies

BackgroundProgrammed cell death protein-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors therapy is now a routine scheme in cancers. However, the effect of preexisting autoantibodies on the safety and efficacy of PD-1/PD-L1 inhibitors in cancer patients is not well understood.MethodsThe pres...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Hui Tang, Ruixuan Geng, Xiuxiu Xu, Yingyi Wang, Jiaxin Zhou, Shulan Zhang, Lin Zhao, Mei Guan, Chunmei Bai
Formáid: Artigo
Teanga:Inglês
Foilsithe: Frontiers Media S.A. 2022-05-01
Sraith:Frontiers in Immunology
Ábhair:
programmed cell death-1
antinuclear antibody
anti-Ro52 antibody
antithyroid antibody
immune-related adverse events
Rochtain Ar Líne:https://www.frontiersin.org/articles/10.3389/fimmu.2022.893179/full
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla